Evidence for ACTN3 as a genetic modifier of Duchenne muscular dystrophy
Duchenne muscular dystrophy is a disease caused by a single gene, characterized by progressive muscle weakness, but is variable between patients partly due to interactions of other genes. Here, the authors show that a commonACTN3polymorphism can modify the clinical phenotype.
Guardado en:
Autores principales: | Marshall W. Hogarth, Peter J. Houweling, Kristen C. Thomas, Heather Gordish-Dressman, Luca Bello, Cooperative International Neuromuscular Research Group (CINRG), Elena Pegoraro, Eric P. Hoffman, Stewart I. Head, Kathryn N. North |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/818c34e56abe46399fd41cf88d337f97 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evaluation of muscular changes by ultrasound Nakagami imaging in Duchenne muscular dystrophy
por: Wen-Chin Weng, et al.
Publicado: (2017) -
Computer task performance by subjects with Duchenne muscular dystrophy
por: Malheiros SRP, et al.
Publicado: (2015) -
Current and emerging treatment strategies for Duchenne muscular dystrophy
por: Mah JK
Publicado: (2016) -
24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy.
por: Elena Stacy Mazzone, et al.
Publicado: (2013) -
Genetic and pharmacological regulation of the endocannabinoid CB1 receptor in Duchenne muscular dystrophy
por: Fabio A. Iannotti, et al.
Publicado: (2018)